Clinical Trials Logo

Tachycardia clinical trials

View clinical trials related to Tachycardia.

Filter by:

NCT ID: NCT01038960 Completed - Clinical trials for Ventricular Tachycardia

Exercise Training in ICD Recipients; Effect on Therapy Delivered, Depression and Anxiety

ETHIC
Start date: April 2008
Phase: Phase 3
Study type: Interventional

Interventional study in patients with ICD. Controlled, open intervention with exercise training. Assessment of changes in physiological and psychological parameters.

NCT ID: NCT01032317 Completed - Atrial Fibrillation Clinical Trials

Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia

EZCF-125
Start date: November 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to study the treatment of Atrial Fibrillation and ischemic Ventricular Tachycardia using a RF ablation catheter with contact force sensing capabilities.

NCT ID: NCT01006746 Completed - Tachycardia Clinical Trials

Observational Study of Patient Comprehension, Perception, Fears and Appreciation Following Home-Monitoring Implementation

Educ@t
Start date: February 2009
Phase: N/A
Study type: Observational

Describe the mutual influences between trainings realized in implantation centers, medico-technical knowledges, technical implementation, perception, fears and appreciation felt by the patients during Home Monitoring implementation.

NCT ID: NCT00989417 Completed - Clinical trials for Ventricular Fibrillation

Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring

ECOST
Start date: January 2007
Phase: N/A
Study type: Interventional

In many aspects of every-day life, modern communication systems bring about a remarkable increase in comfort and safety by transmitting data and information in an easy and reliable manner. In order to provide these advantages also to patients with implantable cardioverter-defibrillators, as well as to their physicians, BIOTRONIK has developed a long-distance implant telemetry to enable periodic trend and event-triggered transmissions of implant data and intracardiac electrogram over distances of several meters. The data is received by a patient device and subsequently automatically transferred to a BIOTRONIK Service Center that provides it to the physician on a password secured internet site. Hence, the physician receives diagnostic information without the patient having to visit the physician (Home Monitoring, HM). New possibilities will arise for a detailed medical and event-correlated supervision of the patient's therapy using electrically active implants.

NCT ID: NCT00982397 Completed - Heart Failure Clinical Trials

Safety and Clinical Performance of the Protecta ICD and CRT-D

Start date: September 2009
Phase: N/A
Study type: Interventional

The purpose of the study is two-fold. In Phase I (Protecta Clinical Study), system performance will be evaluated. In Phase II (PainFree SST), the inappropriate shock-free rate at one year of subjects implanted with a Medtronic Protecta implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) will be evaluated.

NCT ID: NCT00979303 Completed - Clinical trials for Supraventricular Tachycardia

Using Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia

Start date: January 9, 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the additional use of non-fluoroscopic imaging modalities can decrease the use of radiation exposure during standard ablation procedures for supraventricular tachycardia (SVT) in children.

NCT ID: NCT00962949 Completed - Clinical trials for Postural Orthostatic Tachycardia Syndrome (POTS)

The Renin-Aldosterone Axis in Postural Tachycardia Syndrome

Start date: April 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the role of the renin-angiotensin-aldosterone in the pathophysiology of postural tachycardia syndrome, and to provide an insight about the disease process in this disorder.

NCT ID: NCT00940888 Completed - Heart Failure Clinical Trials

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Start date: June 2009
Phase:
Study type: Observational

The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.

NCT ID: NCT00919373 Completed - Clinical trials for Coronary Artery Disease

Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy

VTACH
Start date: July 2002
Phase: N/A
Study type: Interventional

The main objective of this study is to compare the time from randomization to the first recurrence of any ventricular tachycardia (VT) in patients undergoing VT ablation (for stable VTs) and substrate ablation (for unstable VTs) after an initial episode of stable VT and patients not undergoing ablation, with both groups under the protection of an ICD.

NCT ID: NCT00905853 Completed - Clinical trials for Recurrent Ventricular Tachycardia

Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy

VANISH
Start date: May 2009
Phase: Phase 4
Study type: Interventional

This study will compare aggressive antiarrhythmic therapy to catheter ablation for ventricular tachycardia in patients who have suffered prior myocardial infarction. The purpose of this study is to evaluate the optimal management of patients presenting with recurrent VT and receiving ICD therapy in spite of first-line antiarrhythmic drug therapy. The hypothesis is catheter ablation is superior to aggressive antiarrhythmic drug therapy for recurrent VT.